Beyond these key topics, the book delves into the evolution of GPCRs as drug targets, the mechanisms behind their novel functions, and the latest technologies driving research and discovery. It also highlights new and recently approved therapeutic modalities and provides a broad coverage of GPCR ligands. Edited and authored by leading researchers, this book serves as an essential reference for drug discovery researchers and medicinal chemists, as well as AI researchers exploring this drug discovery space.
Table of Contents
I. The Evolution of GPCRs as Drug Targets for Therapy1. GPCRs: From Low Hanging Fruit to Uncharted Territory
2. Orphan GPCRs: New Horizons for GPCR Therapeutics
II. GPCR Mechanisms for Novel Function
3. GPCR Biased Signaling
4. GPCRs as Nature’s Prototype Allosteric Machine
5. GPCRs as Pleiotropic Ligands with Pluridimensional Efficacy
6. Arrestins: Versatile GPCR Partners
III. New Technologies to Investigate GPCR Function
7. The impact of GPCR Structure on New Drug Discovery
8. Conformational Biosensors / TRUPATH
9. The Impact of Computational Chemistry in GPCR Drug Discovery
10. Label Free GPCR Cellular Technologies
11. New GPCR Assays
12. Molecular Dynamics through Cross-linking Mass Spectrometry
13. New Modalities for Drugging GPCRs
14. Artificial Intelligence in Design of GPCR Drugs
15. New Methods to ‘Drug’ GPCRs
16. Impact of Conformational Dynamics on GPCR Drug Discovery
IV. New Therapeutic Modalities for GPCRs
17. GPCR Polypharmacology
18. GPCR Mutation and Human Disease
19. GPCR Phenotypic Signaling in Human Stem Cells
V. GPCR Ligands
20. Biologics and GPCRs
21. Repurposing GPCR Drugs
22. Intracellular GPCR Signaling
23. Antibodies as Drugs for GPCRs